(R)-3-(((Benzyloxy)carbonyl)amino)butanoic acid, 95.0%, 25g

EDTA dipotassium salt dihydrate, min. 99%, for synthesis, 500 g, plastic packaging.

Ethyl 5-oxo-5-(3,4,5-trifluorophenyl)valerate, 97.0%, 1g

6-Bromo-2-isopropylphenol, 97%, 1g

1-Methyl-3-phenyl-1H-pyrazol-4-amine dihydrochloride, 250mg

METHYL (2R)-2-METHYLPYRROLIDINE-2-CARBOXYLATE HCL, 95.0%, 1g

(2-CHLOROETHYL)CYCLOPENTANE, 97%, 250mg

Isophthalamic acid, 95.0%, 1g

Ethyl 4-nitro-1H-pyrrole-2-carboxylate, 95.0%, 1g

1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxamide, 95.0%, 10g

but-2-yne-1,4-diamine dihydrochloride, 95.0%, 2.5g

tert-Butyl (S)-1-(((R)-tert-butylsulfinyl)amino)-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate, 98.0%, 100mg

2-Hydroxy-1-(4-methoxyphenyl)ethanone, 95.0%, 250mg